Memo Therapeutics AG Publishes BKPyV Infection Disease Burden Study in the Journal of Patient-Reported Outcomes

– First conceptual model demonstrating the impact of BK polyomavirus on the health-related quality of life of kidney transplant recipients– Study conducted in partnership with Northwestern University and presented at the World Transplant Congress in August 2025 Schlieren / Zurich, Switzerland, 9 January, 2026 – Memo Therapeutics AG (“MTx”), a late-stage biotech company translating unique […] The post Memo Therapeutics AG Publishes BKPyV Infection Disease Burden Study in the Journal of Patient-Reported Outcomes first appeared on Memo Therapeutics .